Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03093116
Brief Title: A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

First Submitted : March 6, 2017
First Submitted that Met QC Criteria : March 21, 2017
First Posted : March 28, 2017

Last Update Submitted that Met QC Criteria : January 29, 2021
Last Update Posted : February 1, 2021